Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.52 |
| ▸ | HTR7 | P34969 | 2/20 | 0.51 |
| ▸ | HTR1A | P08908 | 1/20 | 0.51 |
| ▸ | DRD2 | P14416 | 1/20 | 0.51 |
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8194970 | 0.88 | ALDH1A1 (0.59) | ALDH1A1KDM4EHTR7HTR1ADRD2 | |
| SCHEMBL7815482 | 0.87 | SLC6A1 (0.50) | — | |
| Hydrochloric Acid SCHEMBL7815587 | 0.86 | SLC6A1 (0.49) | — | |
| SCHEMBL7678661 | 0.79 | ALDH1A1 (0.49) | ALDH1A1KDM4EHTR7HTR1ADRD2 | |
| SCHEMBL7813214 | 0.78 | ALDH1A1 (0.52) | ALDH1A1KDM4EHTR7HTR1ADRD2 | |
| SCHEMBL7681290 | 0.77 | ALDH1A1 (0.51) | ALDH1A1KDM4EHTR7HTR1ADRD2 | |
| SCHEMBL7172276 | 0.76 | ALDH1A1 (0.59) | ALDH1A1KDM4ESMN1; SMN2L3MBTL1MAPT | |
| SCHEMBL8195399 | 0.74 | SLC6A1 (0.64) | ALDH1A1KDM4EHTR7HTR1ADRD2 | |
| SCHEMBL8195393 | 0.74 | SLC6A1 (0.64) | ALDH1A1KDM4EHTR7HTR1ADRD2 | |
| Oxalic Acid SCHEMBL6959081 | 0.74 | ALDH1A1 (0.49) | ALDH1A1KDM4EHTR7HTR1ADRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0869954-B1 | HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF NEUROGENIC INFLAMMATION | NOVO NORDISK AS (DK) | 2001-09-19 | — | — | EP | disclosed |